UPDATES
COVID-19 therapeutics expiry dates and shelf life extensions
Availability and Distribution of Therapeutics
Wyoming currently receives regular allocations of monoclonal antibodies and oral antiviral medications. Guidance on therapeutic management of non-hospitalized adults with COVID-19 can be found here. Healthcare providers can find information about local availability of oral antiviral medications on the therapeutics locator map and therapeutics location data provided by the U.S. Department of Health and Human Services (HHS). Information about monoclonal antibody infusion sites can be found on the HHS monoclonal antibody locator map as well as the National Infusion Center Association map.
Therapeutics Decision Resources
- ASPR: Therapeutics Decision Aid (PDF) A graphic guide to help providers decide which therapeutic options to offer (printable)
- DHSS: COVID-19 Oral Medication Order Form Aid (Word doc)
- NIH: COVID-19 Treatment Guidelines
- IDSA: COVID-19 Treatment Guidelines
- CDC: Information for Healthcare Providers on Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19
CDC: Who is Considered Moderately or Severely Immunocompromised?
Health Partner COVID-19 Therapeutics Ordering Information
The Health Partner Ordering Platform (HPOP) is an ordering portal for allocating and/or requesting therapeutic products. HPOP will be used to order new products (AstraZeneca, Merck, Pfizer, etc). The COVID-19 therapeutics requesting and ordering process is subject to change.
Updates & Ordering Notes
- Remdesivir (Veklury ®) is available by direct ordering from the manufacturer (Gilead): Order link
- Sotrovimab will now be ordered through HPOP and not the COVID-19 Portal.
Health Partner Ordering Platform
Please use the HPOP Provider request form to request access to HPOP.
For more information, please email wdh-therapeutics@wyo.gov.
HHS HPOP Help Desk Information for Users
- For any issues with logging into HPOP, please email cars_helpdesk@cdc.gov
- For password resets, please use the “I forgot my password” link on the sign-in screen
- For any issues with using the HPOP portal, please email HPOP-Therapeutics@hhs.gov
- For general program questions, please email COVID19Therapeutics@hhs.gov
HPOP Provider Resources